@article{5576a2ae8feb4e3fad2abc1c4468253e,
title = "Fluorescent PARP Inhibitors Applied to Intracranial Glioblastoma: Accumulation and Persistence in Vivo",
abstract = "Rucaparib-containing fluorescent probes (1-3) inhibit PARP1 in cell models. One of these (1) was tested in a murine model and shown to permeate into implanted intracranial glioblastoma tumors and persist there for at least 24 h.",
keywords = "MHI-148, PARP inhibitor, cyanine, glioblastoma, rucaparib",
author = "Zhe Gao and Zhen Yang and Zheng Li and Kevin Burgess",
note = "Funding Information: Financial support was provided by the DoD (BC141561), CPRIT (RP170144), and NIH R01EY029645. NMR instrumentation was supported by the NSF (DBI-9970232) and the TAMU System. The use of the Chemistry Mass Spectrometry Facility is acknowledged. Publisher Copyright: {\textcopyright} 2022 American Chemical Society.",
year = "2022",
month = jun,
day = "9",
doi = "10.1021/acsmedchemlett.1c00712",
language = "English (US)",
volume = "13",
pages = "911--915",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "6",
}